AIC
NKTR icon

AWM Investment Company’s Nektar Therapeutics NKTR Stock Holding History

AWM Investment Company’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
20,925
+925
+5% +$67.7K 0.13% 90
2026
Q1 		$1.44M Sell
20,000
-20,000
-50% -$1.14M 0.16% 83
2025
Q4 		$1.69M Hold
40,000
– – 0.16% 87
2025
Q3 		$2.28M Buy
+40,000
New +$1.32M 0.21% 83

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AWM Investment Company's NKTR Position: Q2 2026 in Review

AWM Investment Company increased its Nektar Therapeutics (NKTR) stake by 4.6% in Q2 2026, buying an estimated $67.7K and bringing the position to 20,925 shares worth $1.46M. The position accounts for 0.13% of the portfolio, ranked #90.

AWM Investment Company first reported a position in NKTR in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.28M in Q3 2025. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • AWM Investment Company held 20,925 shares of Nektar Therapeutics worth $1.46M as of Q2 2026.
  • AWM Investment Company bought 925 Nektar Therapeutics shares in Q2 2026, an estimated $67.7K.
  • Nektar Therapeutics made up 0.13% of AWM Investment Company's portfolio in Q2 2026, its #90 holding.
  • AWM Investment Company first reported a position in Nektar Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • AWM Investment Company's Nektar Therapeutics position peaked at $2.28M in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.